3 Reasons to Buy Eli Lilly, and 1 Reason to Sell | The Motley Fool

Jul 11, 2023 · With its share prices up 24% year to date, it appears that the market thinks Eli Lilly's (LLY 1.80%) future looks pretty good. Its performance trounced the comparative 16% …

24%
OFF

3 Reasons To Buy Eli Lilly, And 1 Reason To Sell | The Motley Fool

2 weeks from now

Jul 11, 2023 · With its share prices up 24% year to date, it appears that the market thinks Eli Lilly's (LLY 1.80%) future looks pretty good. Its performance trounced the comparative 16% …

fool.com

20%
OFF

Eli Lilly Just Hit A Milestone That Disappointed. Here's Why You …

2 weeks from now

Nov 8, 2024 · During Q3, Eli Lilly brought in $11.4 billion in sales, up 20% from a year prior, and non-GAAP (adjusted) EPS of $1.18, which was $0.29 less than what the average of Wall …

yahoo.com

24%
OFF

3 Reasons To Buy Eli Lilly, And 1 Reason To Sell - Yahoo

2 weeks from now

Jul 11, 2023 · Investing tends to be concerned with future results, and that means the stock market is often forward-looking. With its share prices up 24% year to date, it appears that the …

yahoo.com

16%
OFF

1 Huge New Reason To Buy Eli Lilly Or Novo Nordisk ... - The …

2 weeks from now

Oct 29, 2024 · As if there weren't enough reasons to buy shares of the cardiometabolic drug juggernauts Eli Lilly (LLY-2.16%) and Novo Nordisk (NVO-2.99%), there's now one more big …

fool.com

17%
OFF

Eli Lilly Stock: 4 Reasons To Buy The Dip After A 17% Drop

2 weeks from now

1 day ago · Eli Lilly & Co. NYSE: LLY is a major global pharmaceutical company in the medical sector.The company made headlines with its dominant GLP-1 drug, Tirzepatide, sold as …

marketbeat.com

61%
OFF

2 Brand-New Reasons To Buy Eli Lilly Stock Right Now, And 2 …

2 weeks from now

Dec 15, 2024 · As a major pharmaceutical company that is constantly innovating and developing new treatments, Eli Lilly (LLY 1.61%) is always providing investors with additional reasons to …

fool.com

5%
OFF

Eli Lilly Shares Down 7.5% As Market Reacts To Slashed Q4 Forecast

2 weeks from now

12 hours ago · Shares of Eli Lilly are down 7.6% today, reflecting market disappointment in the company's adjusted guidance for the fourth quarter of 2024.The pharmaceutical giant expects …

yahoo.com

20%
OFF

Eli Lilly Just Got A Bundle Of Good News: Time To Buy?

2 weeks from now

Dec 4, 2024 · Plenty of reasons to buy. Eli Lilly's shares recently dropped after its third-quarter results did not meet expectations. The company's revenue increased by 20% year over year to …

fool.com

7%
OFF

Eli Lilly Shares Tumble After Cutting Its Sales Outlook. What It Means ...

2 weeks from now

10 hours ago · Shares plunged 7% after management said demand for its popular GLP-1 drugs did not meet expectations.

cnbc.com

6%
OFF

Prediction: These 3 Healthcare Stocks Will Soar In 2025

2 weeks from now

Jan 4, 2025 · It has a diverse portfolio of products, yields 3.6% at the current share price, and has a GLP-1/GIPR combination treatment in the works that could offer serious competition to Eli …

fool.com

59%
OFF

Why Eli Lilly, Novo Nordisk, And Viking Therapeutics ... - The …

2 weeks from now

12 hours ago · Bad news for Eli Lilly (LLY-6.59%) stock dragged down shares of rival companies in the market for GLP-1 diet drugs on Tuesday. Lilly updated investors on its expected …

fool.com

FAQs about 3 Reasons to Buy Eli Lilly, and 1 Reason to Sell | The Motley Fool Coupon?

Is Eli Lilly (LLY) a good stock to buy?

Eli Lilly ( LLY -0.64%) has been one of the better-performing pharma companies of 2020. Year to date, the pharma giant's stock is up by 24.7%, while the SPDR S&P Pharmaceuticals ETF -- an industry benchmark -- is down by 5.5%. There are several reasons Eli Lilly has been beating the market of late. ...

Is Eli Lilly profitable?

Eli Lilly is not only profitable, but the business also generates a ton of free cash flow -- some $5.3 billion over the trailing 12 months. That can help the company pay dividends, buy back shares, and invest in the business itself. And Eli Lilly has been doing all of that: Image source: Eli Lilly Q3 earnings presentation. ...

Is Eli Lilly a good long-term buy?

Another reason Eli Lilly looks like a solid, long-term buy is that it consistently generates impressive profit margins. This is particularly important during a downturn and when facing inflation as it gives the company plenty of a buffer to deal with rising costs and ensures that it can still post a strong profit. 3. ...

Is Eli Lilly outperforming the market?

Eli Lilly has been outperforming — and could continue to outperform — the market. Eli Lilly ( LLY -0.64%) has been one of the better-performing pharma companies of 2020. Year to date, the pharma giant's stock is up by 24.7%, while the SPDR S&P Pharmaceuticals ETF -- an industry benchmark -- is down by 5.5%. ...

What should investors know about Eli Lilly?

In Eli Lilly's case, there are (at least) three misleading tidbits that investors should know about and understand. Let's dive in and analyze why each of these facts are less important than what the stock's detractors assume so that you'll have the full story when it's time to evaluate whether to invest. 1. It's heavily indebted ...

Why did Eli Lilly's stock rise 11%?

The company has defied the broader market sell-off -- with its stock climbing by 11% since the beginning of the year. Eli Lilly owes this performance to a combination of factors. The drugmaker specializes in diabetes medicines, and this chronic illness won't take a break just because we are facing challenging economic conditions. ...